This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Solomon H. Snyder | |
|---|---|
| Name | Solomon H. Snyder |
| Birth date | 1938 |
| Birth place | Baltimore, Maryland |
| Fields | Neuroscience, Pharmacology, Biochemistry |
| Institutions | Johns Hopkins University, National Institutes of Health, Rockefeller University |
| Alma mater | University of Maryland, College Park, Johns Hopkins University School of Medicine |
| Known for | Neurotransmitter receptors, opiate receptors, nitric oxide signaling |
Solomon H. Snyder
Solomon H. Snyder is an American neuroscientist and pharmacologist noted for pioneering discoveries in neurotransmission, receptor biology, and neuromodulation. He trained at the University of Maryland, College Park and Johns Hopkins University School of Medicine and held leadership roles at Johns Hopkins University, the National Institutes of Health, and the Rockefeller University. His work influenced research across neuropharmacology, molecular neuroscience, biochemistry, and psychiatry.
Snyder was born in Baltimore, Maryland and attended local schools before matriculating at University of Maryland, College Park for undergraduate studies and Johns Hopkins University School of Medicine for his MD. During his early training he interacted with faculty at Johns Hopkins Hospital, collaborated with researchers associated with the National Institutes of Health clinical programs, and was influenced by contemporaries from institutions such as Massachusetts General Hospital, Yale University School of Medicine, and Columbia University Vagelos College of Physicians and Surgeons. His medical and research internships connected him with clinicians and scientists from Beth Israel Deaconess Medical Center, University of Pennsylvania Perelman School of Medicine, and Mount Sinai Health System.
Snyder served on the faculty of Johns Hopkins University School of Medicine where he directed laboratories that interacted with departments at Kennedy Krieger Institute, Johns Hopkins Hospital, and the Howard Hughes Medical Institute network. He held visiting and collaborative appointments at the National Institutes of Health, engaged with investigators at the Rockefeller University, and consulted with researchers at Harvard Medical School, Stanford University School of Medicine, and University of California, San Francisco. Snyder was a founding figure in centers that partnered with National Institute of Mental Health, National Institute on Drug Abuse, and private foundations such as the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation.
Snyder's laboratory made landmark identifications of binding sites and receptors, notably mapping opiate receptors that reshaped understanding across pharmacology, neurochemistry, psychiatry, neurosurgery, and addiction medicine. He developed radioligand binding techniques that connected to methods used at Cold Spring Harbor Laboratory, Salk Institute for Biological Studies, and Wistar Institute. Snyder contributed to characterization of neurotransmitter receptors including glutamate and dopamine systems, influencing research at National Institute on Drug Abuse, Rudolf Magnus Institute, and groups at Karolinska Institutet. His work on endogenous opioid peptides linked to discoveries at Imperial College London, University of Cambridge, and University of Oxford that integrated peptide chemistry and receptor pharmacology.
Snyder also participated in early demonstrations of nitric oxide as a neuronal messenger, intersecting with biochemical research at Max Planck Society, Pasteur Institute, and Weizmann Institute of Science, and informing studies in cardiology and neurovascular biology at Cleveland Clinic and Mayo Clinic. His methods for receptor autoradiography and molecular cloning facilitated collaborations with labs at University of California, Berkeley, Johns Hopkins Bloomberg School of Public Health, and Princeton University. Through mentorship and co-authorship he influenced scientists who later became faculty at Yale University, Columbia University, University of Chicago, Northwestern University, and Duke University School of Medicine.
Snyder's achievements were recognized by election to the National Academy of Sciences, the Institute of Medicine (now National Academy of Medicine), and the American Academy of Arts and Sciences. He received major awards from organizations including the Lasker Foundation, the Gairdner Foundation, and the Wolf Foundation, and honors associated with societies such as the American Society for Pharmacology and Experimental Therapeutics, the Society for Neuroscience, and the Royal Society of London (honorary associations). Additional distinctions connected him to philanthropic and scientific bodies like the Johns Hopkins University endowed chairs, the Howard Hughes Medical Institute, and international academies including the London Royal College of Physicians and the Chinese Academy of Sciences (honorary interactions).
Snyder's mentorship produced generations of investigators who took positions at institutions such as Harvard University, Stanford University, Yale University, Columbia University, and University of California, San Francisco. His laboratory culture and publications influenced therapeutic research at pharmaceutical companies including Pfizer, Merck, GlaxoSmithKline, Novartis, and Roche. Snyder maintained professional ties with philanthropic organizations such as the Gordon and Betty Moore Foundation and research consortia including the Allen Institute for Brain Science. His legacy endures in curricula at medical schools like Johns Hopkins University School of Medicine, Perelman School of Medicine at the University of Pennsylvania, and Harvard Medical School and in ongoing work at neuroscience centers worldwide including Massachusetts Institute of Technology, California Institute of Technology, and Broad Institute.
Category:American neuroscientists